ATS Investor Call
Sanofi was pleased to invite investors and analysts to participate in its ATS Investor Call on Monday, May 22, 2023.
(18h00 – 19h30 CEST / 12:00pm – 1:30pm EDT)
Featuring
Dietmar Berger, MD, PhD
Global Head of R&D ad interim
Bill Sibold
Executive Vice President, Specialty Care
Naimish Patel, MD
Therapeutic Area Head, Immunology & Inflammation
Elizabeth Laws, PhD
Global Program Head, Dupixent
Klaus F. Rabe, MD, PhD, FERS
Professor of Medicine, LungenClinic Großhansdorf, Germany
Surya P. Bhatt, MD, MSPH
Associate Professor of Medicine, University of Alabama at Birmingham